SBWire

An investor, who purchased shares of Spirit AeroSystems Holdings, Inc. (NYSE:SPR), filed a lawsuit in the U.S. District Court for the District of Kansas, over alleged violations of Federal Securities Laws by Spirit AeroSystems Holdings, Inc. in connection certain allegedly false and misleading statements made between May 5, 2011 and October 24, 2012.

An investor, who purchased shares of Barrick Gold Corporation (USA) (NYSE:ABX), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of securities laws by Barrick Gold Corporation in connection with certain allegedly false and misleading statements made between May 7, 2009 and May 23, 2013.

An investor, who purchased shares of UniPixel Inc (NASDAQ:UNXL), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by UniPixel Inc in connection certain allegedly false and misleading statements that were made between December 7, 2012 and May 31, 2013 .

A lawsuit on behalf of certain investors in shares of CenturyLink, Inc. (NYSE:CTL) over alleged securities laws violations. Deadline: August 5, 2013. NYSE:CTL investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

An investigation on behalf of investors in ExactTarget Inc (NYSE:ET) shares was announced concerning whether the offer by Salesforce.com to acquire ExactTarget Inc for a value of approximately $33.75 per NYSE:ET share and the takeover process are unfair to investors in ExactTarget shares.

An investigation on behalf of investors in Colonial Properties Trust Inc (NYSE:CLP) shares was announced concerning whether the offer by Mid-America Apartment Communities Inc. to acquire Colonial Properties Trust Inc for a value of approximately $23.72 per NYSE:CLP share and the takeover process are unfair to investors in NYSE:CLP shares.

An investigation on behalf of investors, who continuously held NYSE:ETN shares for several years, was announced concerning whether certain Eaton officers and directors possibly breached their fiduciary duties in connection with certain statements.

An investigation on behalf of current long-term stockholders of shares of TrovaGene Inc (NASDAQ:TROV) was announced concerning whether certain TrovaGene officers and directors possibly breached their fiduciary duties in connection with certain statements.

An investigation on behalf of investors, who currently hold NYSE:IVC shares, was announced concerning whether certain directors and officers of Invacare Corporation breached their fiduciary duties in connection with certain statements made between July 22, 2010 through December 7, 2011.

SkiPlan, which is a leading provider of school ski trips, has just announced its latest special offers for the coming ski season. Amongst the offers that have been announced are details of its ski trips to some top USA resorts, which school trip organisers can now take advantage of by getting in early.

Mobile and internet technology is advancing at an epic pace that hardly seems imaginable. Web based marketing solutions have also been steadily in demand and the market is very competitive that you need every edge you can have in order to stay on top of the food chain.

Women have a lot to consider when preparing for pregnancy, but obese or overweight women also have their weight to monitor and control in order to have a healthy pregnancy and delivery. With obesity rates on the rise, many women are searching for diets that work to reduce their weight before beginning their family. A new study done by the Medical University of South Carolina was interested in the effects of maternal obesity on pregnancy and found that when mothers are overweight or obese, their chances of having problems with pregnancy or delivery were vastly greater than lean mothers. Diet Doc’s hCG weight loss diets offer patients diets that work to eliminate unnecessary and dangerous excess fat and increase their chances of a safer, healthier pregnancy.

TopStockTips.Com Wall Street's #1 Stock Newsletter Alerts Fernhill Corporation (PINKSHEETS: FERN)

IS Group offers excellent signage. IS Group uses the most innovative materials and state-of-the art fabrication processes to produce architectural retail or wayfinding signs. Their in-house design team is skilled at working with existing themes or creating fresh ideas to ensure that the sign is carried out creatively and consistently for optimum branding, function and compliance.

In the 1950s, Dr. A.T. W. Simeons developed the original hCG diet plans that combined low doses of hCG, a hormone that is found in the developing placenta of pregnant women, with very low calorie diets. Patients were successful in losing weight; however, the low caloric intake posed significant health risks to the patient. Benefiting from years of research, Diet Doc has newly modified Simeons' original hCG diet plans, refined the guidelines and now offers the most advanced, fully comprehensive prescription hCG diet plans on today's market.

BestVacuumCleaner.info, a website offering detailed info, reviews as well as other important information related to vacuum cleaners and its uses today announced the commencement of operations. The website is dedicated exclusively for vacuum cleaners available in the market and brings out the related pros and cons to help people make an informed decision. The site also provides real reviews from customers who have already purchased the related product along with offering help in finding the best price option on the same.

Diet Doc understands the challenges people face when trying to lose weight fast and have created hCG diets to provide patients with a quick and effective road to weight management. However, intense cravings and uncontrollable appetite can often lead dieters to make unhealthy food choices, so Diet Doc’s hCG diet plans now utilize an all-natural hormone to help control these cravings while providing expert support and nutrition education, allowing patients to make educated nutrition choices.

Laser tattoo removal works by targeting the pigment in the tattoo ink, this ink has been injected into the dermis layer of a patient’s skin, the dermis is a more stable and permanent layer of skin located below the epidermis, which is constantly being replaced by our bodies.

With aging, the rate at which men burn calories declines and they tend to lose muscle, with the muscle being replaced by fatty tissue. This excess fat puts men at a greater risk for a myriad of weight-related conditions, including the development of a condition called gynecomastia or, simply put, man breasts. Considered a negative feature, man breasts may cause psychological and social effects leading to embarrassment, fear and shame, causing men to avoid activities that may involve removing the shirt. Actually, the development of breasts in men is quite common, with up to 30% of adult males suffering from this embarrassing condition. Although the development of man breasts can be the result of a hormonal imbalance, the most common cause is obesity and excess weight resulting in excess fat being deposited in the chest area.

Jim Kernan, founder of Oriska Insurance, filed lawsuit against NYS Department of Financial Services on behalf of small and minority businesses. James Kernan

Retail volume sales of dried processed food are expected to decline by 1% in 2012 as the category continues to suffer from falling consumption of instant soup, dehydrated soup, dried pasta and instant noodles. All of these categories are expected to register falling demand in 2012 as the spending power of many Polish consumers continues to contract. Moreover, weak consumer spending power has forced a significant proportion of Poles to restrict their expenditure on packaged food to only the most...

GlobalData has released its new PharmaPoint Drug Evaluation report, "Viviant/Combriza (Osteoporosis) - Forecast and Market Analysis to 2022". Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and 2022. Most importantly, the 'gold-standard' bisphosphonates will lose patent protection by end-of-year 2013, flooding the marketplace with less expensive generic versions of these physician-preferred medications. Additionally, Eli Lilly's blockbuster Evista, the only available SERM in the US, will lose patent protection in 2014, flooding the market with yet more affordable generic options. Also during the forecast period covered by this report, osteoporosis drug development research will lead to the launches of a wave of novel anabolic drugs with greater efficacy and safety, causing a major market shift away from anti-resorptive drugs. The number of companies vying for patient share will shrink by as much as 50%, as established players exit the market or acquire smaller players. Lastly, the aging of the population in developed markets will result in a larger patient pool.

GlobalData's clinical trial report, "Rosacea Global Clinical Trials Review, H1, 2013" provides data on the Rosacea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Rosacea. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Rosacea. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Large cooking appliances saw negative growth in volume and current value terms in 2012, with 5% and 1% decreases, respectively. This reduction was a marked difference from the dynamic growth seen in 2011 and 2010 when, due to economic recovery and the need to replace appliances after the earthquake, it achieved growth rates of 23% in volume terms and 54% in current value terms. The growth in 2011 was similar (26% in volume terms and 30% in current value terms) and was motivated by easier access...

GlobalData's clinical trial report, "Vasculitis Global Clinical Trials Review, H1, 2013" provides data on the Vasculitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vasculitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Vasculitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.